JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KOHN, H. I.
Right arrow Articles by HARRIS, J. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by KOHN, H. I.
Right arrow Articles by HARRIS, J. S.
Journal of Pharmacology And Experimental Therapeutics, Vol. 73, Issue 3, 343-361, 1941
Copyright © 1941 by American Society for Pharmacology and Experimental Therapeutics


ON THE MODE OF ACTION OF THE SULFONAMIDES I. ACTION ON ESCHERICHIA COLI

HENRY I. KOHN 1 and JEROME S. HARRIS 1

1 From the Departments of Physiology and Pharmacology, Pediatrics, and Biochemistry, Duke University School of Medicine, Durham, North Carolina

1. Quantitative data on the growth and respiration of E. coli in different media, in the presence and absence of the sulfonamides, has been obtained. Sulfanilamide, sulfapyridine, sulfathiazole and sulfadiazine were employed.

2. The size of inoculum has no real effect on the results. The apparent effect is due to the limitations of the medium and the time course of the inhibition.

3. There is a latent period of sixty to ninety minutes before the action of the sulfonamides on the rate of growth is measurable. Following this, the inhibition develops gradually during the course of three or more hours, depending on the concentration of the drug and the medium.

4. The relationship between rate of growth and drug concentration is plotted. It is simple in a salt-glucose medium, but rather complex in one containing proteose-peptone. These complicated relationships make difficult the evaluation of drug potency and may partly explain the clinical experience that therapeutic result may seem to be independent of sulfonamide blood concentration.

5. They indicate that, as the concentration of the drug is raised, the number of reactions inhibited is increased, and that sulfanilamide cannot inhibit some reaction which is sensitive to the other drugs.

6. At the bacteriostatically active concentrations studied, the sulfonamides do not primarily inhibit the respiration (per cell) of the resting or growing organism.

7. Incubation of non-growing cells with sulfonamide does not affect the subsequent development of inhibition when growth is initiated. Growth was prevented by low temperature, or by withholding ammonia or glucose.

8. A provisional theoretical description of the mode of action of the drug is given.

Submitted on August 4, 1941




This article has been cited by other articles:


Home page
J. Bacteriol.Home page
J. A. Gonzalez-y-Merchand, M. J. Colston, and R. A. Cox
Effects of Growth Conditions on Expression of Mycobacterial murA and tyrS Genes and Contributions of Their Transcripts to Precursor rRNA Synthesis
J. Bacteriol., August 1, 1999; 181(15): 4617 - 4627.
[Abstract] [Full Text]


Home page
J. Bacteriol.Home page
J. A. Gonzalez-y-Merchand, M. J. Colston, and R. A. Cox
Roles of Multiple Promoters in Transcription of Ribosomal DNA: Effects of Growth Conditions on Precursor rRNA Synthesis in Mycobacteria
J. Bacteriol., November 1, 1998; 180(21): 5756 - 5761.
[Abstract] [Full Text]


Home page
ScienceHome page
M. M. ELLIS, B. A. WESTFALL, and M. D. ELLIS
TOXICITY OF DICHLORO-DIPHENYL-TRICHLORETHANE (DDT) TO GOLDFISH AND FROGS
Science, November 24, 1944; 100(2604): 477 - 477.
[PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1941 by the American Society for Pharmacology and Experimental Therapeutics.